CE Marked… But On What Clinical Evidence?
Clinicians should not take CE mark as an alternative to clinical evidence By Nick Woods, http://www.medlatest.com
Latest FDA News
Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
PARSIPPANY, N.J., April 12, 2012 /PRNewswire/ — Custom Spine announced today the 510K Clearance of the Securis cannulated pedicle screw system.
Latest Financial News
Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
Funding Will Support Research, Development, and Availability of Next Generation Non-Surgical Stem Cell Treatments
Latest Products Launches
DePuy Spine launches VIPER F2 transfacet pedicular screw and polyaxial ring system
DePuy Spine, Inc. has announced the launch of the VIPER® F2 Transfacet Pedicular System (VIPER F2), a transfacet pedicular screw and polyaxial ring system designed to provide stabilization and fixation during degenerative lumbar spinal fusion procedures.
Expanding Orthopedics granted a US Patent for expandable device for vertebral compression fractures
Expanding Orthopedics has announced that the United States Patent and Trademark Office has granted a Patent for its novel expandable device for the treatment of vertebral compression fractures.
Clinical Studies
Genetic Mutation Causing Rare Form of Spinal Muscular Atrophy Identified
ScienceDaily (May 10, 2012) — Scientists have confirmed that mutations of a gene are responsible for some cases of a rare, inherited disease that causes progressive muscle degeneration and weakness: spinal muscular atrophy with lower extremity predominance, also known as SMA-LED.
Possible Cause of Movement Defects in Spinal Muscular Atrophy Identified
ScienceDaily — An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests.
Agenda
SAS – International Society for the Advancement of Spine Surgery
Title: SAS – International Society for the Advancement of Spine Surgery Location: Las Vegas, Nevada Link out: Click here Start Date: 2011-04-26 End Date: 2011-04-29
4rd ISMISS Congress
Title: 4rd ISMISS Congress Location: Antalya / Turkey Link out: Click here Description: 4rd ISMISS Congress in Turkey on minimal invasive Spine Surgery and Interventional treatments Start Date: 2011-04-02 End Date: 2011-04-03
Recent Posts
Is it time to update your social media policy?
By Karen M. Cheung With the Federation of State Medical Boards (FSMB) this week releasing new guidelines for physicians on this particular topic, FierceHealthcare is dedicating this week’s commentary to a round-up of the best practices to help hospitals draw on other policies to see what fits at their institutions.
Prolonged Bed Rest as Adjuvant Therapy After Complex Reconstructive Spine Surgery
Rex A. W. Marco MD, Ryan M. Stuckey MD, Stephanie P. Holloway MHA Symposium: Complications of Spine Surgery Volume 470, Issue 6 / June , 2012
How Do Clinical Trials Work?
Clinical trials are research studies to test ways to detect, prevent or treat disease. You might have a family member involved in a clinical trial, or you might be considering whether a clinical trial is an option for you. Choosing to participate in a clinical trial can be a complex decision. You first need to [...]
Genetically Engineered Compound for Back Pain Falls Short
ScienceDaily — Despite the great promise that injecting a new type of anti-inflammatory pain medicine into the spine could relieve the severe leg and lower back pain of sciatica, a Johns Hopkins-led study has found that the current standard of care with steroid injections still does better.
Smith & Nephew First Quarter 2012 Results
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the first quarter ended 31 March 2012.
NuVasive Reports First Quarter 2012 Financial Results
NuVasive, Inc. NUVA -3.43% , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today financial results for the quarter ended March 31, 2012.
